{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T15:45:48Z","timestamp":1741189548072,"version":"3.38.0"},"reference-count":37,"publisher":"JLE","issue":"4","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.nephro.2014.02.005","type":"journal-article","created":{"date-parts":[[2014,6,26]],"date-time":"2014-06-26T13:46:35Z","timestamp":1403790395000},"page":"221-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Actualit\u00e9s sur la prise en charge de l\u2019an\u00e9mie et de la carence martiale du dialys\u00e9"],"prefix":"10.1684","volume":"10","author":[{"given":"Guy","family":"Rostoker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lie","family":"Hummel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Chantrel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Philippe","family":"Ryckelynck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2014.02.005_bib0005","first-page":"279","article-title":"Clinical practice guideline for anemia in chronic kidney disease","volume":"2","author":"Kidney disease improving global outcomes (KDIGO)","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.nephro.2014.02.005_bib0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nephro.2011.04.005","article-title":"Traitement de la carence martiale en pr\u00e9dialyse par l\u2019administration intraveineuse de doses \u00e9lev\u00e9es de fer dextran de bas poids mol\u00e9culaire","volume":"8","author":"Fievet","year":"2012","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.nephro.2014.02.005_bib0015","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1053\/j.ajkd.2008.05.033","article-title":"Intravenous versus oral iron supplementation for the treatment of anemia in CKD: systematic review and meta-analysis","volume":"52","author":"Rozen-Zvi","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2014.02.005_bib0020","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2215\/CJN.04280609","article-title":"Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease?","volume":"5","author":"Stancu","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2014.02.005_bib0025","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/ndt\/16.7.1416","article-title":"The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin","volume":"16","author":"Tessitore","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2014.02.005_bib0030","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1681\/ASN.2006091034","article-title":"Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the dialysis patients\u2019 response to iv iron with elevated ferritin (DRIVE) study","volume":"18","author":"Coyne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2014.02.005_bib0035","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.amjmed.2012.01.015","article-title":"Hemodialysis-associated hemosiderosis in the era of erythropoiesis stimulating agents: a MRI study","volume":"125","author":"Rostoker","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.nephro.2014.02.005_bib0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2215\/CJN.04190510","article-title":"Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease","volume":"6","author":"Ferrari","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2014.02.005_bib0045","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-0609.2012.01783.x","article-title":"Evidence for tissue iron overload in long-term hemodialysis patients and the impact of withdrawing parenteral iron","volume":"89","author":"Ghoti","year":"2012","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.nephro.2014.02.005_bib0050","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.amjmed.2012.02.009","article-title":"Epidemic of iron overload in dialysis population caused by intravenous iron products: a plea for moderation","volume":"125","author":"Vaziri","year":"2012","journal-title":"Am J Med"},{"year":"2012","series-title":"Traitement de l\u2019an\u00e9mie des h\u00e9modialys\u00e9s par solutions de fer IV\u00a0: l\u2019ANSM rappelle la n\u00e9cessit\u00e9 de respecter les sch\u00e9mas posologiques de l\u2019AMM","author":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9, (ANSM)","key":"10.1016\/j.nephro.2014.02.005_bib0055"},{"issue":"5\u00a0Suppl.\u00a03","key":"10.1016\/j.nephro.2014.02.005_bib0060","first-page":"Sl6","article-title":"II. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults","volume":"47","author":"KDOQI National Kidney Foundation","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2014.02.005_bib0065","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/ndt\/gfn653","article-title":"Anemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European renal best practice (ERBP)","volume":"24","author":"Locatelli","year":"2009","journal-title":"Nephrol Dial Transplant"},{"year":"2011","series-title":"Anemia management in people with chronic kidney disease","author":"NICE clinical guideline 39","key":"10.1016\/j.nephro.2014.02.005_bib0070"},{"key":"10.1016\/j.nephro.2014.02.005_bib0075","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1525-139X.2011.00938.x","article-title":"Limiting iron supplementation for anemia in dialysis patients: the basis for Japan's conservative guidelines","volume":"24","author":"Yamamoto","year":"2011","journal-title":"Semin Dial"},{"key":"10.1016\/j.nephro.2014.02.005_bib0080","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0140-6736(82)92204-8","article-title":"Failure of serum ferritin levels to predict bone-marrow iron content after intravenous iron-dextran therapy","volume":"1","author":"Ali","year":"1982","journal-title":"Lancet"},{"year":"2010","series-title":"Handbook of iron overload disorders","author":"Barton","key":"10.1016\/j.nephro.2014.02.005_bib0085"},{"key":"10.1016\/j.nephro.2014.02.005_bib0090","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0140-6736(04)15436-6","article-title":"Non-invasive assessment of hepatic iron stores by MRI","volume":"363","author":"Gandon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2014.02.005_bib0095","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1148\/radiol.2302020820","article-title":"MRI quantification of hepatic iron concentration","volume":"230","author":"Alustiza","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.nephro.2014.02.005_bib0100","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood-2004-01-0177","article-title":"Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonnace","volume":"105","author":"Saint-Pierre","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.nephro.2014.02.005_bib0105","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/bjh.12296","article-title":"The use of appropriate calibration curves correct for systematic differences in liver R2* values measured using different software packages","volume":"161","author":"Meloni","year":"2013","journal-title":"Br J Haematology"},{"key":"10.1016\/j.nephro.2014.02.005_bib0110","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1523-1755.2004.00480.x","article-title":"Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients","volume":"65","author":"Canavese","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2014.02.005_bib0115","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1111\/j.1523-1755.2004.938_7.x","article-title":"Hepatic iron in hemodialysis patients","volume":"66","author":"Fishbane","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2014.02.005_bib0120","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1365-2141.1999.01170.x","article-title":"Kinetic analysis of 52\u00a0Fe-labelled iron (III) hydroxyde-sucrose complex following bolus administration using positon emission tomography","volume":"104","author":"Beshara","year":"1999","journal-title":"Br J Haematol"},{"year":"2012","series-title":"Anemia care is changing dramatically: potential implications of higher iron dosing","author":"Ramirez","key":"10.1016\/j.nephro.2014.02.005_bib0125"},{"year":"2012","series-title":"DOPPS practice monitor: most recent trends in dialysis practice in the US bundled rate era","author":"Robinson","key":"10.1016\/j.nephro.2014.02.005_bib0130"},{"key":"10.1016\/j.nephro.2014.02.005_bib0135","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1681\/ASN.2012121164","article-title":"Infection risk versus maintenance iron supplementation in hemodialysis patients","volume":"24","author":"Brookhart","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2014.02.005_bib0140","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/cs0380191","article-title":"Iron absorption in chronic renal disease","volume":"38","author":"Eschbach","year":"1970","journal-title":"Clin Sci"},{"issue":"1","key":"10.1016\/j.nephro.2014.02.005_bib0145","first-page":"CD007857","article-title":"Parenteral versus oral iron therapy for adults and children with chronic kidney disease","author":"Albaramki","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nephro.2014.02.005_bib0150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ajh.23354","article-title":"Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia","volume":"88","author":"Bregman","year":"2013","journal-title":"Am J Hematol"},{"year":"2013","series-title":"Sp\u00e9cialit\u00e9s \u00e0 base de fer pour injection intraveineuse\u00a0: une utilisation r\u00e9serv\u00e9e aux \u00e9tablissements de sant\u00e9 en raison du risque de r\u00e9actions graves d\u2019hypersensibilit\u00e9","author":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM)","key":"10.1016\/j.nephro.2014.02.005_bib0155"},{"key":"10.1016\/j.nephro.2014.02.005_bib0160","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/ndt\/gft033","article-title":"Kidney disease: improving global outcomes guidelines on anaemia management in chronic kidney disease: a European renal best practice position statement","volume":"28","author":"Locatelli","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2014.02.005_bib0165","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A trial of darbepoetin alfa in type\u00a02\u00a0diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2014.02.005_bib0170","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa062276","article-title":"Normalization of haemoglobin level in patients with chronic kidney disease and anemia","volume":"355","author":"Drueke","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2014.02.005_bib0175","doi-asserted-by":"crossref","first-page":"23","DOI":"10.7326\/0003-4819-153-1-201007060-00252","article-title":"Meta-analysis: erythropoiesis- stimulating agents in patients with chronic kidney disease","volume":"153","author":"Palmer","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nephro.2014.02.005_bib0180","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199808273390903","article-title":"The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin","volume":"339","author":"Besarab","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2014.02.005_bib0185","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1093\/ndt\/gfq305","article-title":"Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial","volume":"25","author":"Carrera","year":"2010","journal-title":"Nephrol Dial Transplant"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725514000479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725514000479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2014.02.005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T15:00:07Z","timestamp":1741186807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725514000479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1769725514000479"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2014.02.005","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Actualit\u00e9s sur la prise en charge de l\u2019an\u00e9mie et de la carence martiale du dialys\u00e9","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2014.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Association Soci\u00e9t\u00e9 de n\u00e9phrologie. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}